Latest filing published 24 Jul 2026 for VYNE Therapeutics Inc., €18k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Tyler Zeronda in Yarrow Bioscience, Inc. The record holds 26 filings, for trades running from 30 June 2021 to 23 July 2026.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 24 July 2026 with a share grant (€18k) in Yarrow Bioscience, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 26 declarations